Barbara Bosier

1.1k total citations
20 papers, 651 citations indexed

About

Barbara Bosier is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Barbara Bosier has authored 20 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 16 papers in Cellular and Molecular Neuroscience and 5 papers in Molecular Biology. Recurrent topics in Barbara Bosier's work include Cannabis and Cannabinoid Research (16 papers), Neuroscience and Neuropharmacology Research (11 papers) and Neurotransmitter Receptor Influence on Behavior (11 papers). Barbara Bosier is often cited by papers focused on Cannabis and Cannabinoid Research (16 papers), Neuroscience and Neuropharmacology Research (11 papers) and Neurotransmitter Receptor Influence on Behavior (11 papers). Barbara Bosier collaborates with scholars based in Belgium, France and United Kingdom. Barbara Bosier's co-authors include Emmanuel Hermans, Didier M. Lambert, Giulio G. Muccioli, Koen Van Laere, Guy Bormans, Régis Millet, Patrick Depreux, Jean‐Pierre Hénichart, Deborah M. Lambert and Jacques H. Poupaert and has published in prestigious journals such as FEBS Letters, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Barbara Bosier

20 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Bosier Belgium 16 418 345 203 63 60 20 651
Alvin R. King United States 8 399 1.0× 331 1.0× 289 1.4× 61 1.0× 33 0.6× 8 716
Shu Yu United States 10 593 1.4× 455 1.3× 204 1.0× 51 0.8× 88 1.5× 11 772
Linda Console‐Bram United States 10 375 0.9× 247 0.7× 170 0.8× 61 1.0× 48 0.8× 13 563
Evgueni V. Berdyshev United States 12 643 1.5× 216 0.6× 130 0.6× 59 0.9× 107 1.8× 13 747
Ankur Kapur United States 8 388 0.9× 285 0.8× 302 1.5× 40 0.6× 38 0.6× 11 613
Carmen Rodríguez‐Cueto Spain 14 449 1.1× 314 0.9× 129 0.6× 64 1.0× 33 0.6× 24 618
Stéphane St-Onge Canada 13 160 0.4× 270 0.8× 367 1.8× 91 1.4× 193 3.2× 18 702
Danielle Saya Israel 12 349 0.8× 535 1.6× 365 1.8× 124 2.0× 55 0.9× 16 792
Huy Khang Vu Canada 6 376 0.9× 428 1.2× 218 1.1× 186 3.0× 53 0.9× 8 682
Andy Billinton United Kingdom 13 222 0.5× 205 0.6× 235 1.2× 139 2.2× 27 0.5× 22 673

Countries citing papers authored by Barbara Bosier

Since Specialization
Citations

This map shows the geographic impact of Barbara Bosier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Bosier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Bosier more than expected).

Fields of papers citing papers by Barbara Bosier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Bosier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Bosier. The network helps show where Barbara Bosier may publish in the future.

Co-authorship network of co-authors of Barbara Bosier

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Bosier. A scholar is included among the top collaborators of Barbara Bosier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Bosier. Barbara Bosier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taccola, Giuliano, Arnaud Steyaert, Anne des Rieux, et al.. (2016). A new model of nerve injury in the rat reveals a role of Regulator of G protein Signaling 4 in tactile hypersensitivity. Experimental Neurology. 286. 1–11. 11 indexed citations
2.
Bosier, Barbara, Carlos Alberto Manssour Fraga, Eliezer J. Barreiro, et al.. (2015). Partial agonism and fast dissociation of LASSBio-579 at dopamine D2 receptor. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 62. 1–6. 2 indexed citations
3.
Bosier, Barbara, et al.. (2015). Inhibition of the regulator of G protein signalling RGS4 in the spinal cord decreases neuropathic hyperalgesia and restores cannabinoid CB1 receptor signalling. British Journal of Pharmacology. 172(22). 5333–5346. 18 indexed citations
4.
Bosier, Barbara, Luigi Bellocchio, Mathilde Metna‐Laurent, et al.. (2013). Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes. Molecular Metabolism. 2(4). 393–404. 68 indexed citations
5.
Bosier, Barbara, Giulio G. Muccioli, Birgit Mertens, et al.. (2012). Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivo. Neuropharmacology. 62(7). 2328–2336. 23 indexed citations
6.
Bosier, Barbara, Giulio G. Muccioli, & Didier M. Lambert. (2012). The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB1‐ and FAAH‐independent mechanisms. British Journal of Pharmacology. 169(4). 794–807. 20 indexed citations
7.
Focant, M., et al.. (2011). Increasing the density of the D2L receptor and manipulating the receptor environment are required to evidence the partial agonist properties of aripiprazole. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 36(1). 60–70. 20 indexed citations
8.
Vandeputte, Caroline, Nele Evens, Jaan Toelen, et al.. (2011). A PET Brain Reporter Gene System Based on Type 2 Cannabinoid Receptors. Journal of Nuclear Medicine. 52(7). 1102–1109. 43 indexed citations
9.
Bosier, Barbara, Giulio G. Muccioli, Emmanuel Hermans, & Didier M. Lambert. (2010). Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities. Biochemical Pharmacology. 80(1). 1–12. 149 indexed citations
10.
Casteels, Cindy, et al.. (2010). Influence of chronic bromocriptine and levodopa administration on cerebral type 1 cannabinoid receptor binding. Synapse. 64(8). 617–623. 9 indexed citations
11.
Gérard, Nathalie, Jenny Ceccarini, Guy Bormans, et al.. (2010). Influence of Chronic Nicotine Administration on Cerebral Type 1 Cannabinoid Receptor Binding: An In Vivo Micro-PET Study in the Rat Using [18F]MK-9470. Journal of Molecular Neuroscience. 42(2). 162–167. 20 indexed citations
12.
Bosier, Barbara, Sophie Sarre, Ilse Smolders, et al.. (2010). Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists. Neuropharmacology. 59(6). 503–510. 21 indexed citations
13.
Bosier, Barbara, Emmanuel Hermans, & Deborah M. Lambert. (2008). Differential modulation of AP‐1‐ and CRE‐driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1receptor. British Journal of Pharmacology. 155(1). 24–33. 22 indexed citations
14.
Bosier, Barbara, Didier M. Lambert, & Emmanuel Hermans. (2008). Reciprocal influences of CB1cannabinoid receptor agonists on ERK and JNK signalling in N1E‐115 cells. FEBS Letters. 582(28). 3861–3867. 20 indexed citations
15.
Evens, Nele, Barbara Bosier, Brian J. Lavey, et al.. (2008). Labelling and biological evaluation of [11C]methoxy-Sch225336: a radioligand for the cannabinoid-type 2 receptor. Nuclear Medicine and Biology. 35(7). 793–800. 30 indexed citations
16.
Goffin, Karolien, Guy Bormans, Cindy Casteels, et al.. (2008). An in vivo [18F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam. Neuropharmacology. 54(7). 1103–1106. 27 indexed citations
17.
Bosier, Barbara, Emmanuel Hermans, & Didier M. Lambert. (2008). Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB1 cannabinoid receptor agonists on tyrosine hydroxylase expression. Biochemical Pharmacology. 77(2). 216–227. 8 indexed citations
18.
Bosier, Barbara & Emmanuel Hermans. (2007). Versatility of GPCR recognition by drugs: from biological implications to therapeutic relevance. Trends in Pharmacological Sciences. 28(8). 438–446. 51 indexed citations
19.
Bosier, Barbara, et al.. (2007). Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell line. Journal of Neurochemistry. 102(6). 1996–2007. 24 indexed citations
20.
Stern, Eric, Giulio G. Muccioli, Barbara Bosier, et al.. (2007). Pharmacomodulations around the 4-Oxo-1,4-dihydroquinoline-3-carboxamides, a Class of Potent CB2-Selective Cannabinoid Receptor Ligands:  Consequences in Receptor Affinity and Functionality. Journal of Medicinal Chemistry. 50(22). 5471–5484. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026